NBP Latest Press Releases

-- October 28, 2026 --

NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer Globe Newswire 7:00 AM

-- October 25, 2026 --

NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development Globe Newswire 7:00 AM

-- October 20, 2026 --

Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia Globe Newswire 7:00 AM

-- October 13, 2026 --

Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China PRNewswire 7:00 AM

Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis Globe Newswire 7:00 AM

-- October 8, 2026 --

NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026 Globe Newswire 4:05 PM

-- September 8, 2026 --

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director Globe Newswire 7:00 AM

-- August 27, 2026 --

NovaBridge Biosciences to Participate in September Investor Conferences Globe Newswire 7:00 AM

-- August 20, 2026 --

NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution Globe Newswire 7:00 AM

-- August 13, 2026 --

NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 Globe Newswire 5:00 PM

-- July 24, 2026 --

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 Globe Newswire 5:00 PM

-- June 29, 2026 --

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer Globe Newswire 7:00 AM

-- June 16, 2026 --

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes